LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,137,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mint Tower Capital Management B.V. | 12,000,000 | $19,882,000 | 4.94% |
| CQS Cayman LP | 25,000,000 | $41,458,000 | 2.86% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,245,000 | $20,273,000 | 2.64% |
| TFG Asset Management GP Ltd | 6,100,000 | $10,116,000 | 1.50% |
| CSS LLC/IL | 11,490,000 | $19,090,000 | 0.93% |
| ANGELO GORDON & CO., L.P. | 8,500,000 | $14,068,000 | 0.69% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,500,000 | $45,566,000 | 0.68% |
| Verition Fund Management LLC | 3,200,000 | $5,312,000 | 0.52% |
| SHENKMAN CAPITAL MANAGEMENT INC | 2,932,000 | $4,867,000 | 0.44% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $7,962,000 | 0.30% |